Women’s health startup Evvy has raised $40 million in a Series B funding round to build the datasets and AI infrastructure that precision medicine in women’s health has been missing.
Founded in 2021 by Priyanka Jain, Laine Bruzek, and Pita Navarro, Evvy now serves over 100,000 patients. Evvy offers data-driven, personalized at-home Vaginal Health Tests for vaginal infections, fertility, menopause, and more.
Catalio Capital Management led the Series B funding round with participation from new investors Rethink Impact, Muse Capital, and Alumni Ventures, alongside existing investors LabCorp Venture Fund, General Catalyst, Left Lane Capital, BBG Ventures, Amboy Street Ventures, Ingeborg, Foreground Capital, and Flywheel Ventures.
Jacob Vogelstein, Co-Founder and Managing Partner at Catalio Capital Management, said: “We were drawn to Evvy not only because of its growth, but because of the unique data and AI infrastructure the company is building, and the exceptional team executing on it.”
“Its combination of proprietary data, clinical evidence, and a growing biomarker discovery engine creates an entirely new foundation for precision women’s healthcare. We believe Evvy is building the data platform that will define this category for decades to come,” added Jacob Vogelstein.
Personalized Health
Evvy’s funding round comes amid a surge in investor interest in personalized health solutions. Digital health startups, including at-home test providers, have raised more than $20 billion in venture capital funding so far this year.
The personalized health sector has recorded several notable VC deals more recently. In a notable funding round, Function Health, a provider of membership-based personalized health and wellness tests, announced the closing of a $450 million new growth funding round from General Catalyst’s Customer Value Fund.
In another deal, Lucis, an AI-powered personalized health guidance companion app, raised $20 million in a Series A round, led by Singular, with participation from General Catalyst, Y Combinator, and angels including investors behind Runna, Céline Lazorthes (Resilience), and Manu Lecomte.